17
answers
2
watching
311
views

When it comes to using clinical data collected outside of the US to support a US regulatory submission, it’s important to understand that:

a. FDA expects clinical trial design and conduct to conform with relevant local regulations and applicable Good Clinical Practices

b. FDA looks critically at data obtained from foreign studies in terms of its applicability to the US patient population

c. FDA reserves the right to audit foreign clinical sites to confirm whether or not the data is valid for the purposes of obtaining an approval to market a device in the U.S

d. All of the above

For unlimited access to Homework Help, a Homework+ subscription is required.

Avatar image
Liked by mehdotstorm and 1 others

Unlock all answers

Get 1 free homework help answer.
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in
Avatar image
Read by 2 people
Already have an account? Log in
Avatar image
Read by 1 person
Already have an account? Log in

Related questions

Related Documents

Weekly leaderboard

Start filling in the gaps now
Log in